vimarsana.com

Latest Breaking News On - Drugmaker wockhardt - Page 1 : vimarsana.com

Wockhardt Q4 results: Reports net loss of ₹177 crore; antibiotic products show progress

Wockhardt Limited reports reduced net loss, plans to launch new antibiotics, files patents, and raises funds for growth.

Wockhardt raises Rs 480 crore to pare debt, fund drug trial

Wockhardt plans to clear debt, fund antibiotic trials with QIP funds. Khorakiwala expects revenue growth, EBITDA rise, and completion of global antibiotic trial for innovations like WCK5222 and WCK4873.

Wockhardt upbeat on Phase III pneumonia study results involving antibiotic candidate

Wockhardt upbeat on Phase III pneumonia study results involving antibiotic candidate
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Wockhardt upbeat on Phase III pneumonia study results involving antibiotic candidate

Wockhardt upbeat on Phase III pneumonia study results involving antibiotic candidate
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Wockhardt says Guardian Finance wrongfully invoked pledge on 20 lakh shares

Wockhardt says Guardian Finance wrongfully invoked pledge on 20 lakh shares
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.